The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Role of the combination of 3 T whole-body MRI and 18F-FDG PET/CT in the management of multiple myeloma and smoldering myeloma: The new era of imaging.
 
Claudio Cerchione
Honoraria - Abbvie; Amgen; Astellas Pharma; BeiGene; Bristol-Myers Squibb; Curis; GlaxoSmithKline; GlycoMimetics; ImmunoGen; Janssen; Jazz Pharmaceuticals; Karyopharm Therapeutics; Menarini; Oncopeptides; Pfizer; Sanofi; SERVIER; Skyline Diagnostics; Stemline Therapeutics; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; BeiGene; Bristol-Myers Squibb; Curis; GlaxoSmithKline; GlycoMimetics; ImmunoGen; Janssen; Jazz Pharmaceuticals; Karyopharm Therapeutics; Menarini; Oncopeptides; Pfizer; Sanofi; SERVIER; Skyline Diagnostics; Stemline Therapeutics; Takeda
Speakers' Bureau - Abbvie; Amgen; Astellas Pharma; BeiGene; Bristol-Myers Squibb; Curis; GlaxoSmithKline; GlycoMimetics; ImmunoGen; Janssen; Jazz Pharmaceuticals; Menarini; Oncopeptides; Pfizer; Sanofi; SERVIER; Skyline Diagnostics; Stemline Therapeutics; Takeda
 
Davide Bezzi
No Relationships to Disclose
 
Delia Cangini
No Relationships to Disclose
 
Davide Nappi
No Relationships to Disclose
 
Michela Ceccolini
No Relationships to Disclose
 
Sonia Ronconi
No Relationships to Disclose
 
Nicola Normanno
Honoraria - Amgen; AstraZeneca; Biocartis; Illumina; Incyte; Lilly; Merck Serono; MSD; MSD; Novartis; Novartis; SERVIER; SOPHiA Genetics; Thermo Fisher Scientific
Consulting or Advisory Role - AstraZeneca; Bayer; Biocartis; Incyte; Novartis; Roche
Research Funding - AstraZeneca (Inst); Biocartis (Inst); Illumina (Inst); Incyte (Inst); Merck Serono (Inst); Qiagen (Inst); Roche (Inst); SOPHiA Genetics (Inst); Thermo Fisher Scientific (Inst)
Travel, Accommodations, Expenses - Merck Serono
 
Gerardo Musuraca
No Relationships to Disclose
 
Matteo Marchesini
No Relationships to Disclose
 
Giovanni Martinelli
No Relationships to Disclose
 
Alice Rossi
No Relationships to Disclose